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Abstract
Vacuolar H-ATPase (V-ATPase) is responsible for acidification of intracellular compartments in eukaryotic cells. Its 16-
kDa subunit (proteolipid, PL16) plays a central role in V-ATPase function, forming the principal channel via which protons
are translocated. To elucidate physiological roles of V-ATPase in mammalian cell function and embryogenesis, we attempted
to generate a PL16 null mutant mouse by gene-targeting. Mice heterozygous (PL16=3) for the proteolipid mutation were
intercrossed and their offspring were classified according to genotype. There were no homozygous (PL163=3) pups among
69 neonates examined, but a few PL163=3 embryos were found during the pre-implantation stages of embryonic
development, up to day 3.5 post-coitum. These results suggested that PL16 (and hence V-ATPase) may play an essential role
in cell proliferation and viability during early embryogenesis. PL16=3 mice were indistinguishable from their wild-type
littermates and displayed no discernible abnormalities, although the PL16 mRNA level in PL16=3 mice decreased to about
one-half of wild-type levels. ß 1999 Elsevier Science B.V. All rights reserved.
1. Introduction
Vacuolar H-ATPases (V-ATPases) are ubiquitous
in eukaryotic cell endomembranes, such as those en-
closing vacuoles, lysosomes, coated vesicles, secretory
granules and the trans-Golgi network [1^8]. In these
organellar membranes, V-ATPases pump H into
the lumen of the organelles in a process coupled
with ATP hydrolysis, leading to acidi¢cation of or-
ganellar compartments. In a number of di¡erentiated
cell types, including osteoclasts [9], kidney epithelial
cells [10] and macrophages [11], V-ATPases are also
enriched in the plasma membranes, where they ac-
tively secrete H from the cells and establish an
acidic extracellular environment. This process is in-
volved in bone resorption, urinary acidi¢cation and
cytoplasmic pH regulation. In situ hybridization
studies have shown increasing speci¢city of localiza-
tion of the 16-kDa V-ATPase subunit (proteolipid,
PL16) mRNA to sites of mesenchymal di¡erentiation
and epithelium^mesenchyme interaction from about
day 17 of rat embryogenesis, suggesting the speci¢c
involvement of V-ATPase in mammalian late embry-
onic development [12]. However, the functional im-
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portance of V-ATPase during mammalian early em-
bryogenesis remains to be determined.
V-ATPases are composed of multiple subunits and
assembled as a large membrane complex that has a
structure similar to that of H-ATP synthase (F1Fo-
ATPase) [1^8]. V-ATPases have two distinct multi-
subunit sectors, a hydrophilic sector (V1) carrying a
catalytic center for ATP hydrolysis and a hydropho-
bic sector (Vo) which functions as an H channel. In
mammalian cells, V1 appears to have at least eight
distinct subunits (designated A^H). Although the
number of essential subunits in Vo is not certain, at
least four distinct subunits of 115, 39, 20 and 16 kDa
are involved. Of these, the 16-kDa subunit PL16
plays a central role in H translocation across the
membrane [13].
In microorganisms, especially budding yeast, dis-
ruption of subunit genes has provided much infor-
mation concerning the physiological roles of V-ATP-
ase. Disruption of the budding yeast gene encoding a
V-ATPase subunit was conditionally lethal, showing
sensitivity to environmental factors such as alkaline
pH and several metal ions [14]. Dow et al. reported
that deletion of the gene encoding the B subunit of
V-ATPase in Drosophila lead to larval lethality,
whereas point mutations caused defective phenotypes
ranging from subvital to embryonic lethal [15]. How-
ever, no mammalian V-ATPase gene knockouts have
yet been described.
In order to elucidate the physiological roles of
mammalian V-ATPase, we attempted to disrupt the
proteolipid gene in mice. Although we readily ob-
tained heterozygotes (PL16=3), homozygous knock-
out mice were not produced, indicating that V-ATP-
ase is essential in very early embryogenesis.
2. Materials and methods
2.1. Construction of the targeting vector
The mouse PL16 gene was isolated from a 129/Sv
genomic library (Stratagene) by a standard plaque
hybridization method [16], using rat proteolipid
cDNA [17] as a probe. The targeting vector con-
tained approximately 10.4 kb of genomic sequence.
The initiation codon AUG of the proteolipid gene in
the targeting vector was replaced with an EcoRI rec-
ognition sequence, into which the neomycin-resist-
ance gene (neo) without a promoter and a polyA
sequence were inserted. The gene for diphtheria toxin
A fragment with an MC1 promoter [18] was inserted
into the construct at a HindIII site to provide a
marker for negative selection. The targeting vector
was linearized with XhoI before being transfected
into ES cells (Fig. 1).
2.2. Isolation of targeted ES cell clones
ES cell line CJ7 [19], kindly provided by Dr. T.
Gridley (Roche Institute of Molecular Biology), was
cultured on an inactivated embryonic ¢broblast
feeder layer. Gene transfer experiments were carried
out by electroporation [20] and transfected clones
were cultured on a G418-resistant feeder layer (Gib-
co). G418-resistant ES clones were isolated after 10^
14 days of culture in medium containing 150 Wg/ml
of geneticin (Gibco) and expanded further in 24-well
plates.
Homologous recombinants were identi¢ed by
Southern blot analysis [16]. Genomic DNA was pre-
pared from cells cultured in the absence of feeder
cells and subjected to Southern blot analysis. Total
DNA (10 Wg) was cleaved with BamHI and EcoRI,
resolved by agarose gel electrophoresis, blotted onto
Hybond N+ membrane (Amersham), and hybridized
to probe A (Fig. 1). Probe A is a 1.0-kb HindIII^
HindIII fragment £anking the 3P-end of the targeting
vector. The probe hybridized to a 6.3-kb fragment of
the wild-type allele and a 1.8-kb fragment of the
mutant allele. To ensure integration of a single tar-
geting vector in the transformed ES clones, DNAs
were digested with SacI, Southern blotted as above
and hybridized with probe B (Fig. 1), which is the
complete coding sequence of the neomycin-resistance
gene (0.8 kb).
2.3. Generation of chimeric and heterozygous mice
Eight-cell embryos were collected from pregnant
Crj:CD-1 (ICR) or C57BL/6 females 2.5 days post-
coitum (dpc). Approximately 8^10 ES cells carrying
a homologous recombination were microinjected into
the embryos [21] and implanted into pseudopregnant
ICR foster mothers. Chimeras identi¢ed by the pres-
ence of an agouti coat color were test-mated with
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C57BL/6 females. Agouti o¡spring were tested for
the targeted PL16 gene by Southern blot analysis
using probe A as above (Fig. 1).
2.4. Genotyping of embryos
Postimplantation embryos (8.5 and 14.5 dpc) ob-
tained from heterozygous intercrosses were geno-
typed by Southern blot analysis as described above.
Preimplantation embryos (1.5^3.5 dpc) were ana-
lyzed using a PCR-based method [22]. Brie£y, pre-
implantation embryos collected from oviducts and
uteri were washed several times with phosphate-bu¡-
ered saline (PBS; pH 7.3), suspended in 7.5 Wl of
double-distilled water, frozen with liquid nitrogen,
thawed and digested with proteinase K (0. 25 mg/
ml ¢nal concentration) for 1 h at 55‡C. After incu-
bation for 10 min at 95‡C, the embryo extracts were
used as templates for PCR analysis. Nested PCR was
performed using primers P1 (5P-TTG CCT CCT
CGC TCG CTG TCC CGT T-3P) and P2 (5P-GCG
CCC ATG ACA CCG AAA AAC GAA G-3P),
which are complementary to the 5P-non-coding re-
gion and exon 1 of the PL 16 gene, respectively,
followed by primers P3 (5P-CCT TGA ATT CAT
GGG ATC GGC CAT TGA AC-3P) and P4 (5P-
CCT TGA ATT CCC CTC AGA AGA ACT CGT
C-3P), which match the N-terminal and C-terminal
ends of the neomycin-resistance gene, respectively
(Fig. 3). The ¢rst round of nested PCR was carried
out using 10 Wl of embryo extract under the follow-
ing conditions: ¢rst cycle, 180 s at 95‡C, 120 s at
55‡C and 90 s at 72‡C, followed by 40 cycles, each
consisting of 60 s at 95‡C, 30 s at 55‡C and 90 s at
72‡C. The product of the ¢rst-round PCR was di-
luted 1:100 and 2 Wl of this dilution was used as
the target of the second PCR (30 cycles, each con-
sisting of 60 s at 95‡C, 30 s at 55‡C and 90 s at
72‡C). The resulting PCR products were resolved
by 5% polyacrylamide gel electrophoresis (PAGE)
and visualized with UV light after staining with ethi-
dium bromide.
2.5. Northern blot analysis of heterozygous mice
Total cellular RNA was extracted from various
tissues of wild-type and heterozygous (PL16=3)
mice using Isogen solubilizing solution (Wako, Osa-
ka, Japan), which is based on the guanidium isothio-
cyanate method [23]. For Northern blot analysis,
15 Wg of total RNA from di¡erent mouse tissues
was denatured with formaldehyde, separated by elec-
trophoresis on 1% agarose gels, and transferred onto
Hybond N+ membrane (Amersham). Membranes
were prehybridized with bu¡er containing Den-
hardt’s solution [24], and hybridized with radiola-
beled rat DNA encoding PL16 as a probe. Hybrid-
izing bands were visualized and quanti¢ed using a
Bio-Image Analyzer BAS1000 (Fuji). In order to
normalize total RNA loading, the membranes were
stripped by boiling and then reprobed with a cDNA
encoding glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) [25].
2.6. DNA manipulation and sequencing
Preparation of plasmids, digestion with restriction
endonucleases, ligation of the DNA fragments with
T4 DNA ligase and other techniques related to han-
dling of DNA were performed according to standard
procedures [16,26]. The nucleotide sequences of in-
serts cloned into the various expression plasmids in
this study were determined by dideoxynucleotide
chain termination reactions using K-35S deoxy-CTP
(37 TBq/mol, Amersham) and T7 DNA polymerase
[27] and subsequent autoradiography, or by auto-
mated sequencing using £uorescent primers (Pharma-
cia Biotech).
2.7. Reagents and enzymes
Restriction endonucleases, T4 DNA ligase, Tth
and Pfu DNA polymerases and T7 DNA polymerase
were purchased from Toyobo, New England Biolabs,
and Takara. Oligonucleotides were synthesized by
Pharmacia Biotech. Other reagents and materials
were of the highest grade commercially available.
3. Results
3.1. Generation of ES cells and mice with a mutated
proteolipid gene
We found that only one copy of functional gene
and two defective pseudogenes of 16 kDa proteolipid
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exist in mouse based on sequence analyses of cloned
genes and hybridization analyses of the whole mouse
genome (Noumi et al., manuscript in preparation). A
targeting vector for disrupting the proteolipid gene
was constructed using the ¢rst exon of the only func-
tional gene derived from 129Sv genomic DNA (Nou-
mi et al., manuscript in preparation). The genes en-
coding neomycin resistance (neo) and diphtheria
toxin A fragment were included in the construct as
positive and negative selection markers [18], respec-
tively. The coding region of neo was inserted into an
EcoRI site which was created by substitution of the
initiation codon of the proteolipid gene (Fig. 1).
Consequently, the ¢rst AUG of the proteolipid
gene was replaced by that of the neo gene. The tar-
geting vector was introduced into ES cells by electro-
poration and ES cells showing increased resistance to
G418 were selected. Homologous recombination in
the selected clones was identi¢ed by Southern blot
analysis with probe A (Fig. 1). The presence of the
targeted alleles was con¢rmed by detection of a
1.8-kb EcoRI^EcoRI fragment created by recombi-
nation, compared with a 6.3-kb EcoRI^BamHI frag-
ment from the wild-type allele (Fig. 1, Fig. 2A). Six
clones carrying the targeted allele were found in 297
colonies. In all of the selected clones, a probe con-
Fig. 1. Structures of proteolipid gene in mouse genome, targeting vector, homologous recombinant allele and Southern blotting
probes. (A) Structure of proteolipid gene in mouse genome. Ex.1, Ex.2 and Ex.3 indicate exons 1^3. Closed and open boxes indicate
coding and non-coding regions, respectively. (B) Structure of targeting vector. The coding region of the neomycin-resistance gene
(neo) was inserted into the translation initiation site of the proteolipid gene, which had been mutated to create an EcoRI restriction
site. DT-A indicates diphtheria toxin A fragment gene with MC1 promoter. (C) Structure of homologous recombinant (targeted) al-
lele. (D) DNA fragment used as a probe for Southern blot analysis and the sizes of bands expected in the analyses shown in Fig. 2.
B, BamHI; E, EcoRI; H, HindIII; S, SacI; X, XbaI.
Table 1
Genotypes of liveborn o¡spring and embryos derived from het-
erozygote intercrosses
(+/+) (+/3) (3/3) Total
Liveborn o¡spring 22 47 0 69
Embryos
E14.5 10 20 0 30
E8.5 13 23 0 36
E3.5 8 23 1 32
E2.5 9 24 4 37
E1.5 2 10 3 15
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taining the neo gene (probe B; Fig. 1) hybridized
with fragments of the expected sizes on Southern
blots (Fig. 2A).
The mutant ES clones were microinjected into
eight-cell embryos of ICR or C57BL/6 mice. A
germ-line chimera (male) was obtained from embryos
injected with one of the mutant ES clones. The chi-
meric mouse was then bred to produce mice hetero-
zygous for the mutation. The heterozygous mice
(PL16=3) thus created were viable and fertile. The
PL16=3 mice were then intercrossed and the geno-
types of the resulting o¡spring determined. A typical
result is shown in Fig. 2B. Among 69 o¡spring pro-
duced by mating of PL16=3 mice, none was found
to be homozygous for the mutation (PL163=3). The
ratio of wild-type (PL16=) to PL16=3 mice was
approximately 1:2, based on the result shown in
Table 1. Crosses of PL16=3 and wild-type mice (ei-
ther male or female) produced PL16=3 and wild-
type o¡spring in a ratio of about 1:1 (data not
shown). These results indicate that PL163 germ
cells, both spermatozoa and ova, were of normal
fertility and that PL163=3 mice died during develop-
ment.
3.2. Loss of proteolipid leads to early embryonic
lethality
Embryo genotypes were analyzed by Southern blot
or PCR (Fig. 3) at di¡erent times during gestation in
order to determine when embryos of the PL163=3
mice died. No PL163=3 embryos were found at post-
implantation stages 8.5 and 14.5 dpc (Table 1). How-
ever, when embryos were recovered at preimplanta-
tion stages (1.5^3.5 dpc) from the oviducts and uteri
of naturally mated PL16=3 mice, a few PL163=3
embryos were detected: one at 3.5 dpc (blastocyst
stage), four at 2.5 dpc (eight-cell stage) and three at
1.5 dpc (two-cell stage) (Table 1). The ratio of
PL163=3 to total embryos was clearly lower than
the Mendelian ratio even at 2.5 dpc (eight-cell stage).
These data indicate that loss of function of the en-
dogenous proteolipid gene resulted in early embry-
onic lethality during pre-implantational develop-
Fig. 2. Genotype analysis of ES cell lines and liveborn o¡spring derived from heterozygote intercrosses by Southern blot analysis.
(A) Genomic DNA prepared from wild-type (+/+) and targeted (+/3) ES clones were digested with both BamHI and EcoRI, or with
SacI alone, and hybridized to probes A and B as indicated. (B) Genomic DNA prepared from liveborn o¡spring of heterozygote in-
tercrosses were digested and probed as above. (+/+) and (+/3) represent wild-type and heterozygous mice, respectively.
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ment, and that proteolipid (and hence V-ATPase ac-
tivity) may be essential for basal cell growth in mam-
malian cells. No abnormalities were observed in the
blastocyst or eight-cell PL163=3 embryos by phase
contrast microscopy.
3.3. mRNA level of proteolipid gene in heterozygous
mice
Mice heterozygous for the PL16 mutation were
indistinguishable from wild-type mice with respect
Fig. 4. PL16 mRNA levels in heterozygous knockout and wild-type mice. Northern blot analysis (A) of wild-type and heterozygous
mice was performed using rat proteolipid cDNA as a probe. Expression levels of the proteolipid gene were normalized using GAPDH
as an internal control. (B). Open and closed bars represent relative expression levels in wild-type and heterozygous mice, respectively.
Fig. 3. Genotype analysis of embryos derived from heterozygote intercrosses by PCR. (A) Schematic representation of the wild-type
and targeted alleles, and the primers used for genotyping of embryos. PCR primers P1^P4 are indicated by arrows. A 130-bp DNA
fragment is ampli¢ed from the wild-type allele by the ¢rst PCR using P1 and P2 as primers, whereas a 900-bp fragment is obtained
from the targeted allele. Since the 900-bp fragment was very faint, the targeted allele was detected as an 800-bp fragment by nested
PCR using primers P3 and P4 for the second round. Ex.1, exon 1 of the proteolipid gene; 5PNC, 5P-non-coding region; CR, coding
region of exon 1. (B) Genotype analysis of E2.5 embryos. PCR was performed as above. The lower and upper arrows represent 130-
and 900-bp products, respectively, in the ¢rst PCR. An arrow indicates the 800-bp DNA product of the second PCR. (+/+), wild-
type; (+/3), heterozygote; (3/3), homozygote.
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to body weight and posture, and did not exhibit
anatomical abnormalities (data not shown).
Although we had expected that the heterozygotes
might show some abnormality because of the early
embryonic lethality of the homozygotes and the im-
portance of V-ATPase in cellular functions [28^30],
this was not the case. We therefore compared PL16
mRNA levels in the PL16=3 and wild-type mice.
Northern blotting and hybridization of total RNA
prepared from various organs revealed that PL16
mRNA levels were 50% lower in the PL16=3 mice
than in the PL16= mice, suggesting that the pro-
teolipid content of PL16=3 embryos may be lower
than that of wild-type embryos (Fig. 4).
4. Discussion
We attempted to generate mice with a null muta-
tion of the gene for the proteolipid subunit of V-
ATPase. In result, newborns and embryos homozy-
gous for the mutant proteolipid gene were not de-
tected after the blastocyst stage. V-ATPase may
therefore be essential for early embryogenesis. It
should be noted that the proteolipid gene is one of
relatively few genes whose knockout caused early
embryonic lethality. Disruption of genes encoding
Rad51, a factor involved in DNA repair and homol-
ogous recombination, and E-cadherin, a cell adhe-
sion molecule, is known to cause pre-implantational
lethality [21,31^33]. Tsuzuki et al. proposed that mu-
tants leading to peri-implantational death might be
divided into two categories: those that cause abnor-
mal formation of tissues, and those that cause loss of
basic molecular functions required for general cell
viability [21]. E-cadherin might belong in the former
category, which also includes abnormal cell^cell
communication, and Rad51 might belong to the lat-
ter group. It has been reported that lysosome-like
acidic vacuoles in blastocyst trophoblast cells play
an important role in implantation of embryos [34].
The defect caused by disruption of the PL16 gene
may therefore involve abnormal formation of tissue.
However, we found that even at the eight-cell stage
the ratio of PL163=3 to total embryos does not ¢t
Mendelian predictions. In eight-cell embryos, the
cells do not inter-communicate extensively and are
relatively independent of each other [35,36]. It there-
fore appears that early embryonic lethality caused by
dysfunction of V-ATPase may in fact be due to a
defect in cell growth and viability.
Speci¢c inhibitors of V-ATPase function (ba¢lo-
mycin and concanamycin and its derivatives) cause
inhibition of vesicle transport and protein sorting
in cultured cells [28,29,37,38]. Recently, antibiotics
were shown to cause programmed cell death in sev-
eral cultured cell lines [39^41]. The mechanism
underlying these observations has remained obscure,
but there are a few clues available. Acidi¢cation of
cytoplasmic pH caused by inhibition of V-ATPase
induces apoptosis-like cell death in the murine B
lymphoma cell line WEHI-231 [39]. Moreover, ex-
pression of p53, a tumor suppresser gene, is en-
hanced when apoptosis is induced by inhibition of
V-ATPase in cardiomyocytes [41]. These observa-
tions suggest that an apoptotic mechanism may
underlie the early embryonic lethality observed in
proteolipid knockout mice.
Mice heterozygous for p53 [42^44], neuro¢broma-
tosis type I or II [45^47] or vascular endothelial
growth factor (VEGF) [48,49] genes show serious
defects, such as tumorigenesis or abnormal blood
vessel development, respectively, although most of
the heterozygote knockout mice reported to date
have been indistinguishable from wild-type litter-
mates. Mice heterozygous for the proteolipid null
mutation displayed no discernible abnormalities,
although the PL16 mRNA level in the heterozygotes
was approximately one-half of the level observed in
their wild-type littermates. It would be of interest to
compare the internal pH of various cellular compart-
ments in wild-type and PL16=3 mice, and to survey
histochemical abnormalities in the heterozygous
mice.
Here we report that a null mutation of the proteo-
lipid gene caused early embryonic lethality, suggest-
ing that V-ATPase is essential for early embryogen-
esis. In order to further analyse the function(s) of V-
ATPase in the later stages of embryogenesis and in
speci¢c tissues in postnatal mice, stage- and tissue-
speci¢c conditional disruptions will be required. Het-
erozygous knockout mice constructed in this study
will be a useful tool for such work. Null mutations
of other subunits of V-ATPase will also be important
for further evaluation of the gene knockout reported
in this article, and of V-ATPase function.
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